These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23931806)

  • 1. Porphyric neuropathy.
    Lin CS; Park SB; Krishnan AV
    Handb Clin Neurol; 2013; 115():613-27. PubMed ID: 23931806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyric neuropathy.
    Albers JW; Fink JK
    Muscle Nerve; 2004 Oct; 30(4):410-22. PubMed ID: 15372536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyric neuropathy.
    Gandhi Mehta RK; Caress JB; Rudnick SR; Bonkovsky HL
    Muscle Nerve; 2021 Aug; 64(2):140-152. PubMed ID: 33786855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute porphyrias: pathogenesis of neurological manifestations.
    Meyer UA; Schuurmans MM; Lindberg RL
    Semin Liver Dis; 1998; 18(1):43-52. PubMed ID: 9516677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute hepatic porphyria and its neurological syndrome].
    Bont A; Steck AJ; Meyer UA
    Schweiz Med Wochenschr; 1996 Jan; 126(1-2):6-14. PubMed ID: 8571113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and acute porphyrias: reasons for a hazardous relationship.
    Roveri G; Nascimbeni F; Rocchi E; Ventura P
    Postgrad Med; 2014 Nov; 126(7):108-20. PubMed ID: 25387219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovisceral porphyrias: what a hematologist needs to know.
    Bonkovsky HL
    Hematology Am Soc Hematol Educ Program; 2005; ():24-30. PubMed ID: 16304355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
    Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
    Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological manifestations of acute intermittent porphyria.
    Pischik E; Kauppinen R
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):72-83. PubMed ID: 19268005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.
    Kazamel M; Desnick RJ; Quigley JG
    Curr Neurol Neurosci Rep; 2020 Oct; 20(12):56. PubMed ID: 33026560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute porphyrias - A neurological perspective.
    Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
    Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purple pigments: the pathophysiology of acute porphyric neuropathy.
    Lin CS; Lee MJ; Park SB; Kiernan MC
    Clin Neurophysiol; 2011 Dec; 122(12):2336-44. PubMed ID: 21855406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute hepatic porphyrias: current status and future challenges.
    Siegesmund M; van Tuyll van Serooskerken AM; Poblete-Gutiérrez P; Frank J
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):593-605. PubMed ID: 20955962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.
    Anderson KE; Desnick RJ; Stewart MF; Ventura P; Bonkovsky HL
    Am J Med Sci; 2022 Jan; 363(1):1-10. PubMed ID: 34606756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.
    Naik H; Stoecker M; Sanderson SC; Balwani M; Desnick RJ
    Mol Genet Metab; 2016 Nov; 119(3):278-283. PubMed ID: 27595545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria.
    Lindberg RL; Martini R; Baumgartner M; Erne B; Borg J; Zielasek J; Ricker K; Steck A; Toyka KV; Meyer UA
    J Clin Invest; 1999 Apr; 103(8):1127-34. PubMed ID: 10207164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency.
    Thunell S; Henrichson A; Floderus Y; Groth CG; Eriksson BG; Barkholt L; Nemeth A; Strandvik B; Eleborg L; Holmberg L
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):599-606. PubMed ID: 1493152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
    Sardh E; Harper P
    J Intern Med; 2022 May; 291(5):593-610. PubMed ID: 35067977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.